FULC logo

Fulcrum Therapeutics, Inc.

FULC
Healthcare|Biotechnology|US
$3.70
+0.02 (+0.54%)
DCF Value
$3.01
Tangible Book / Share
$4.07
Cash / Share
$4.18
Next Earnings Report
Mar 2, 2027
EPS est. -$0.05
Financing Filings (last 12 months)
3
Shelf registrations / offering prospectuses — latest Nov 4, 2026 (424B3). Possible dilution.

Upcoming Data Readouts (0)

No upcoming completion dates found in active trials.

Recent Press Releases

Kaplan Fox is Investigating Claims Against Fulcrum Therapeutics, Inc. (FULC) on Behalf of Investors
Oct 8, 2026 · Newsfile Corp
Kaplan Fox Encourages Fulcrum Therapeutics, Inc. (FULC) Investors Who Suffered Losses to Learn About Their Legal Rights
Oct 6, 2026 · Newsfile Corp
Kaplan Fox Investor Alert: Fulcrum Therapeutics, Inc. (FULC) Investigated for Possible Securities Law Violations
Oct 2, 2026 · Newsfile Corp
Kaplan Fox is Investigating Fulcrum Therapeutics, Inc. (FULC) and its Board for Possible Securities Law Violations
Sep 30, 2026 · Newsfile Corp
Kaplan Fox Notifies Fulcrum Therapeutics, Inc. (FULC) Investors of a Pending Securities Investigation
Sep 28, 2026 · Newsfile Corp
Kaplan Fox Alerts Fulcrum Therapeutics, Inc. (FULC) Investors: The Firm is Investigating Possible Securities Law Violations
Sep 24, 2026 · Newsfile Corp
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Centerspace (NYSE – CSR), Fulcrum Therapeutics, Inc. (Nasdaq – FULC), Weave Communications, Inc. (NYSE – WEAV), Personalis, Inc. (Nasdaq – PSNL)
Sep 23, 2026 · GlobeNewsWire
Kaplan Fox Broadens its Investigation of Fulcrum Therapeutics, Inc. (FULC) for Possible Securities Law Violations
Sep 22, 2026 · Newsfile Corp
Kaplan Fox Encourages Investors of Fulcrum Therapeutics, Inc. (FULC) to Learn More About the Firm's Investigation
Sep 18, 2026 · Newsfile Corp
Kaplan Fox Shareholder Alert: Fulcrum Therapeutics, Inc. (FULC) is Under Investigation for Possible Securities Law Violations
Sep 16, 2026 · Newsfile Corp

SEC Filings (81)

Last two years from EDGAR. Insider Form 4s are on the Ownership tab.

FiledFormWhat it isLinks
Nov 4, 2026EFFECTDocumentIndex
Nov 4, 2026424B3Offering prospectusDocumentIndex
Nov 3, 2026S-4/ADocumentIndex
Oct 28, 2026SC 13G/APassive 5%+ stakeDocumentIndex
Oct 27, 2026SC 13G/APassive 5%+ stakeDocumentIndex
Oct 20, 2026S-4/ADocumentIndex
Oct 8, 2026S-4/ADocumentIndex
Sep 2, 2026S-4DocumentIndex
Aug 17, 2026425DocumentIndex
Aug 17, 2026425DocumentIndex
Aug 17, 2026425DocumentIndex
Aug 17, 20268-KMaterial eventDocumentIndex
Aug 14, 2026SC 13G/APassive 5%+ stakeDocumentIndex
Aug 14, 2026SC 13GPassive 5%+ stakeDocumentIndex
Aug 14, 2026SC 13G/APassive 5%+ stakeDocumentIndex
Aug 14, 2026SC 13G/APassive 5%+ stakeDocumentIndex
Aug 10, 20268-KMaterial eventDocumentIndex
Aug 3, 2026SC 13GPassive 5%+ stakeDocumentIndex
Jul 30, 202610-QQuarterly reportDocumentIndex
Jul 28, 2026SC 13G/APassive 5%+ stakeDocumentIndex
Jul 17, 2026SC 13GPassive 5%+ stakeDocumentIndex
Jul 15, 2026SC 13G/APassive 5%+ stakeDocumentIndex
Jun 25, 2026SC 13GPassive 5%+ stakeDocumentIndex
Jun 25, 2026SC 13GPassive 5%+ stakeDocumentIndex
Jun 25, 20268-KMaterial eventDocumentIndex
Jun 11, 20268-KMaterial eventDocumentIndex
Jun 10, 2026SC 13GPassive 5%+ stakeDocumentIndex
Jun 4, 20268-KMaterial eventDocumentIndex
Jun 1, 20268-KMaterial eventDocumentIndex
May 15, 2026SC 13G/APassive 5%+ stakeDocumentIndex
May 15, 2026SC 13G/APassive 5%+ stakeDocumentIndex
Apr 30, 2026DEFA14AProxy / shareholder voteDocumentIndex
Apr 30, 2026ARSAnnual report to holdersDocumentIndex
Apr 30, 2026DEF 14AProxy / shareholder voteDocumentIndex
Apr 27, 202610-QQuarterly reportDocumentIndex
Apr 27, 20268-KMaterial eventDocumentIndex
Mar 26, 2026SC 13G/APassive 5%+ stakeDocumentIndex
Feb 24, 2026S-8Employee stock planDocumentIndex
Feb 24, 202610-KAnnual reportDocumentIndex
Feb 24, 20268-KMaterial eventDocumentIndex